UMIN-CTR History

Name:  UMIN ID:


Unique ID issued by UMIN UMIN000013513
Receipt number R000007653
Scientific Title Phase 2 clinical trial of primary systemic therapy for primary breast cancer Sequential regimen of Nab-Paclitaxel followed by EC for HER2 negative breast cancer and concurrent regimen of Docetaxel/Carboplatin/Herceptin for HER2 positive breast cancer
Date of disclosure of the study information 2014/03/25
Last modified on 2014/03/25 19:58:36

No. Disposal Last modified on Item of update
1 Insert 2014/03/25 19:59:00